Analyst Bullish Momentum Builds Around Compass Therapeutics
Multiple analysts initiate bullish coverage on Compass Therapeutics (CMPX), highlighting promising data for lead drug tovecimig and strong pipeline potential.
/ 1 item
#CMPX↓